https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-28.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2021-06-22 08:11:392021-06-22 08:11:39Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug
Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute's Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.
https://pioneerinstitute.org/wp-content/uploads/Screen-Shot-2021-06-10-at-10.46.32-AM.png 516 920 Isabel Wagner https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Isabel Wagner2021-06-14 10:00:412021-06-15 09:50:37Comparing Covid-19 Vaccination and New Infection Rates in Suffolk County: Is Vaccination Working?
Massachusetts ranks fourth nationally for the highest percent…
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-24.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2021-05-25 09:56:002021-05-25 10:24:27Origin of COVID-19: As Animal Source Evidence Eludes Scientists, Lab Leak Hypothesis Gains Purchase
This week on Hubwonk, host Joe Selvaggi talks with author and former New York Times science journalist Nicholas Wade about his recent article in the Bulletin of the Atomic Scientists on the possible origins of the SARS2 virus that caused the COVID-19 pandemic. In their conversation, they consider the possibility that, absent finding evidence of a natural jump from animals, the SAR2 virus may have come from a lab.
https://pioneerinstitute.org/wp-content/uploads/Guest-christina-qi-2.png 1570 3000 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2021-05-06 10:09:042021-05-06 10:09:04Amar Sawhney on Sikhs, STEM & COVID
On this week's episode of JobMakers, host Denzil Mohammed talks to Dr. Amar Sawhney about his journey from India to Boston, and how he is using his chemical engineering background to save lives through remarkable local therapy innovations. To date, he has founded eight companies accounting for 4,000 jobs and more than $2 billion in revenue.
https://pioneerinstitute.org/wp-content/uploads/Copy-of-WordPress-Blog-Post-Featured-Image-2.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2021-04-16 07:30:472021-04-26 10:01:55COVID-19 Vaccine Tracker
Pioneer is proud to present a new vaccine tracker, the newest tool in our COVID-19 tracking project. Pioneer distilled the vaccination data down to those who are either fully vaccinated or partially vaccinated, by all the demographic categories published by the DPH. Use the new tool below to compare rates among groups, by municipality and by county. We will update the data every week.
https://pioneerinstitute.org/wp-content/uploads/Five-Reasons-Why-Drug-Rebates-Are-Harmful-to-Patients-and-to-the-Healthcare-System-15.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2020-12-08 10:05:032020-12-08 10:05:28COVID-19 Vaccine: The End of the Epidemic is Within Reach
Join Host Joe Selvaggi and Virologist and Investor Dr. Peter Kolchinsky as they discuss the rapid development, efficacy, and rollout of the newly approved COVID-19 vaccines.
https://pioneerinstitute.org/wp-content/uploads/The-Potry-of-Jazz-7.png 1440 2560 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2020-09-08 10:01:452021-02-15 16:07:15Drug Rebates: How Pharmacy Benefit Managers Manipulate Price & Limit Choice
Join host Joe Selvaggi and his guest Dr. Bill Smith as they discuss the complex incentive structure between drug manufacturers, health plans, and pharmacy benefit managers. In this episode, they focus on how drug rebates work and how a system intended to optimize value may actually deliver higher costs and fewer choices. Joe and Bill also use this framework to speculate on the price of a COVID-19 vaccine, and who will likely pay for it.
https://pioneerinstitute.org/wp-content/uploads/The-Learning-Curve-15.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2020-05-26 12:17:252020-05-28 09:42:20Hubwonk Ep. 7: Covid Testing: What went wrong, where we are & when we’ll get closer to normalcy
https://pioneerinstitute.org/wp-content/uploads/Fresh-Aqua-Summit-1.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2020-05-21 05:48:362020-07-17 13:41:29Study Finds Pandemic Likely to Negatively Impact Biopharmaceutical Sector
Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a new Pioneer Institute study finds many companies will emerge from the pandemic commercially weaker, dealing with delays in new product launches and with fewer resources to invest in research and development.
https://pioneerinstitute.org/wp-content/uploads/Common-Core-Debacle-6.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2020-05-05 10:41:082020-05-25 11:27:24Conquering COVID-19: When and From Where Will Vaccines and Therapies Emerge?
This week on Hubwonk, Host Joe Selvaggi is joined by Pioneer’s Bill Smith, Visiting Fellow in Life Sciences, and Dr. Peter Kolchinsky, Harvard-trained virologist, biotech investor and author of the new book, The Great American Drug Deal, to learn how the SARS-CoV2 works, what a vaccine may look like, and how we might produce it to scale.
https://pioneerinstitute.org/wp-content/uploads/Green-Grunge-Basketball-Quote-UAAP_NCAA-Twitter-Post-1.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2020-04-02 06:00:242020-12-11 13:28:28New Report: Quality Adjusted Life Years (QALY) Methodology Discriminates Against Older Americans, Threatens to Deny Seniors Access to Life-Saving Care
New report asserts that with older americans more vulnerable during the COVID-19 pandemic, all health plans should avoid using the QALY methodology when assessing the value of care for older patients